Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
(3) check purity 98% (99% preferred)
FOXO4-DRI is a first-in-class senolytic peptide that selectively eliminates senescent "zombie cells" by disrupting the FOXO4-p53 interaction
They are produced from the same proglucagon precursor and are co-secreted by intestinal L-cells, but their downstream effects, drug-development trajectories, and FDA-approval status are very different
In fact, clinically significant bone loss typically happens over the course of years , Dr
Its unique mechanism, hypothesized to involve direct DNA interaction rather than surface receptor binding, sets it apart from other bioregulator peptides
US$ 20.52
US$ 20.65
US$ 27.53
US$ 21.20
US$ 23.16
US$ 22.59
US$ 26.03
US$ 21.26
US$ 20.51
US$ 27.84
